血脂异常
代谢综合征
医学
疾病
胰岛素抵抗
生物信息学
重症监护医学
肥胖
糖尿病
生物
内科学
内分泌学
作者
Nasimudeen R. Jabir,Chelapram K. Firoz,Mohd Imran Khan,Syed Kashif Zaidi,Ghulam Md Ashraf,Shazi Shakil,Mohammad Amjad Kamal,Shams Tabrez
标识
DOI:10.2174/1389200217666160810155055
摘要
Cerebrovascular disease (CD) and metabolic syndrome (MetS) are two devastating health dilemma that continues to be a potential contributor to disability and mortality in human population all across the world. Scientific data clearly shows several mechanistic similarities between these two co-existing and interlinked conditions. The linkage exacerbates ongoing patho-physiological condition towards more lethal events. In view of the presence of modifiable risk factors in both CD and MetS, their management holds potential therapeutic value. Hence, developing common treatment strategies for these diseases could involve common molecular agents. In this communication, we have summarized some of the common pathological conditions viz. abdominal obesity, insulin resistance, dyslipidemia, hypertension, and endothelial dysfunction that further deteriorate existing homeostasis in CD and MetS. Based on our article, it is advocated that substantial improvements in novel multi-targeted drug discovery could provide the effective treatment methods in order to avoid the fatal complications related with CD and MetS.
科研通智能强力驱动
Strongly Powered by AbleSci AI